Retour sur lavenir.net
   WDP 21.740 € (-0,09 %)     VASTNED 29.550 € (+0,17 %)     EVS 29.600 € (-0,67 %)     AB INBEV 70.420 € (-0,25 %)     ACKERMANS V.HAAREN 287.800 € (+0,21 %)     COLRUYT 34.120 € (-2,51 %)     KINEPOLIS GROUP 35.450 € (+0,42 %)     ASCENCIO 51.700 € (0,00 %)     RECTICEL 10.860 € (+2,45 %)     CMB.TECH 12.420 € (-4,02 %)     DEME GROUP 181.800 € (-1,62 %)     SOFINA 221.400 € (-0,81 %)     MELEXIS 83.000 € (+2,79 %)     VAN DE VELDE 30.000 € (-1,32 %)     CIE BOIS SAUVAGE 302.000 € (-1,31 %)     ATENOR 1.770 € (+1,72 %)     BEKAERT 42.100 € (-0,94 %)     PROXIMUS 6.165 € (-1,52 %)     KBC 119.050 € (-0,67 %)     CELYAD ONCOLOGY 0.267 € (-0,74 %)     ARGENX SE 762.800 € (-2,23 %)     AGEAS 67.200 € (-0,81 %)     FAGRON 23.750 € (-0,84 %)     SOLVAC NOM(RETAIL) 77.500 € (+0,65 %)     XIOR 26.000 € (0,00 %)     GIMV 44.650 € (-0,89 %)     TESSENDERLO 20.600 € (0,00 %)     HOME INVEST BE. 19.400 € (-0,41 %)     SHURGARD 24.150 € (+0,84 %)     ELIA GROUP 131.700 € (-1,42 %)     WERELDHAVE BELGIUM 52.200 € (-0,38 %)     ENERGYVISION 14.440 € (-1,90 %)     D'IETEREN GROUP 165.000 € (-1,43 %)     LOTUS BAKERIES 11 260.000 € (-0,35 %)     CAMPINE 222.000 € (-3,06 %)     VIOHALCO 19.740 € (+2,28 %)     FLUXYS BELGIUM D 19.650 € (-1,01 %)     AZELIS GROUP 9.800 € (-2,29 %)     KBC ANCORA 81.800 € (-0,97 %)     TUBIZE-FIN 218.200 € (-1,27 %)     OXURION 0.004 € (-10,00 %)     TITAN S.A. 54.300 € (+1,50 %)     DECEUNINCK 2.275 € (-2,36 %)     IMMOBEL 24.000 € (+4,35 %)     CARE PROPERTY INV. 12.440 € (+0,48 %)     CENERGY 24.980 € (+5,22 %)     UMICORE 23.720 € (-0,92 %)     VGP 82.400 € (+1,60 %)     ONTEX GROUP 2.430 € (+0,41 %)     TINC 11.640 € (-0,51 %)     WHAT'S COOKING GP 145.500 € (+0,34 %)     QUESTFOR GR-PRICAF 2.978 € (+0,12 %)     AGFA-GEVAERT 0.416 € (-0,95 %)     RETAIL ESTATES 68.900 € (-0,86 %)     SOLVAY 27.800 € (+0,58 %)     BARCO 8.690 € (+0,52 %)     BREDERODE 102.400 € (-0,78 %)     SYENSQO 67.600 € (-1,74 %)     JENSEN-GROUP 83.000 € (-0,72 %)     IBA 16.100 € (-3,71 %)  
   ASML HOLDING 1 676.000 € (+1,18 %)     BASTIDE LE CONFORT 23.500 € (-0,21 %)     DERICHEBOURG 9.955 € (-1,73 %)     SOITEC 116.500 € (-6,58 %)     SANOFI 73.340 € (-2,06 %)     LUMIBIRD 24.650 € (+0,20 %)     SCHNEIDER ELECTRIC 291.000 € (+2,92 %)     HAFFNER ENERGY 0.253 € (-6,99 %)     THALES 232.600 € (+0,69 %)     SAFRAN 333.500 € (+2,93 %)     LVMH 505.100 € (-1,15 %)     MAROC TELECOM 9.100 € (+0,44 %)     ARCELORMITTAL SA 55.860 € (-3,39 %)     EUTELSAT COMMUNIC. 2.375 € (-7,01 %)     CIECHARGEURSINVEST 8.260 € (-1,78 %)     CARREFOUR 15.425 € (-6,17 %)     VINCI 130.650 € (+0,27 %)     BNP PARIBAS ACT.A 101.100 € (-0,10 %)     AXA 42.400 € (-0,31 %)     AHOLD DEL 34.520 € (-2,46 %)     SAINT GOBAIN 79.760 € (+1,12 %)     ADYEN 903.800 € (+1,74 %)     PROSUS 39.090 € (-0,31 %)     AIR LIQUIDE 167.120 € (+0,13 %)     LAKEFRONT BIOTHER. 24.580 € (-0,73 %)     EURONEXT 146.300 € (-1,48 %)     EDENRED 24.230 € (+17,17 %)     SPIE 50.450 € (+0,30 %)     WOLTERS KLUWER 58.200 € (-2,68 %)     ONE EXPERIENCE 0.362 € (-15,54 %)     NANOBIOTIX 30.400 € (-0,91 %)     MOTA ENGIL 4.598 € (-2,38 %)     SAFE 0.570 € (+1,79 %)     STELLANTIS NV 5.570 € (-3,65 %)     SCOR SE 31.140 € (-0,70 %)     REMY COINTREAU 45.420 € (+2,76 %)     WINAMP GROUP 0.386 € (-1,28 %)     LLAMA GROUP 0.386 € (-1,28 %)     VALEO 13.410 € (-5,06 %)     EXAIL TECHNOLOGIES 106.400 € (+0,66 %)     RAMSAY GEN SANTE 11.000 € (-1,35 %)     AIRBUS 191.940 € (+2,63 %)     JCDECAUX 19.380 € (-1,42 %)     INNATE PHARMA 1.598 € (+1,14 %)     BE SEMICONDUCTOR 317.800 € (+2,48 %)     VERALLIA 19.480 € (-2,01 %)     PLANISWARE 18.000 € (-3,23 %)     AKZO NOBEL 59.620 € (+1,05 %)     SHELL PLC 34.210 € (-2,56 %)     RELX 27.220 € (-4,02 %)     VOPAK 45.100 € (-0,88 %)     ASM INTERNATIONAL 1 070.500 € (+2,34 %)     THERMADOR GROUPE 69.300 € (-0,72 %)     OSE IMMUNO 3.584 € (-4,32 %)     BOLLORE 5.400 € (-0,74 %)     LECTRA 16.660 € (+0,73 %)     KERING 276.550 € (+4,40 %)     BUREAU VERITAS 26.210 € (+0,54 %)     ALTAREA 96.300 € (-0,52 %)     IMERYS 22.520 € (-0,09 %)  
News Réglementées
19/01/2023 15:00

Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street

SHERMAN OAKS, CA / ACCESSWIRE / January 19, 2023 / Avenir Wellness Solutions, Inc. (f/k/a CURE Pharmaceutical Holding Corp.) (OTCQB:CURR), a proprietary broad platform technology and wellness company ("Avenir" or the "Company") announced that it is launching an informational series to inform the Wall Street community about its unique dual revenue model involving breakthrough consumer wellness products and intellectual property monetization. Avenir has retained producer New to The Street to create sponsored television content featuring Avenir's leadership that will be nationally and internationally syndicated on major television networks.

Avenir's management will introduce themselves to New to The Street's viewers and provide updates about the Company's science-based delivery systems for their wellness, skincare/beauty, and new market disruptive products. Filmed discussions will occur at the on-site studios, New York Stock Exchange, Nasdaq MarketSite, or off-site through Zoom video calls. Each segment is to air across New to The Street's syndicated televised platforms on Newsmax TV and FOX Business Network, and as a sponsored program on Bloomberg TV.

Nancy Duitch, CEO of Avenir Wellness Solutions, stated, "I'm excited to highlight the Company's strategic trajectory, new delivery technologies, and our new and unique product launches. New to The Street offers a media presence that enables us to share the Company's milestones and value propositions of our current 15 patents, strong retail presence, nutraceuticals, and patented topical delivery systems. We are all looking forward to introducing ourselves and explaining the business growth plans to the New to The Steet audience."

New to The Street expects each televised airing to bring attention to Avenir's operations and how they are developing new cutting-edge technologies and building the foundation of the Company. Avenir has uniquely positioned itself to enhance its market share within its multi-billion-dollar industry.

Vince Caruso, the Creator / Producer of New to The Street, stated, "We expect fantastic TV interviews with the Avenir management team, who will share exciting business updates and developments with our viewers. And we at New to The Street TV anticipate maximizing viewership interest in Avenir's numerous business platforms, products, and patents. I feel that our audience will receive a comprehensive understanding of their business operations and future growth expectations."

About Avenir Wellness Solutions, Inc. (f/k/a CURE Pharmaceutical Holding Corp.)
Avenir Wellness (OTCQB:CURR) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that will be part of its incubator strategy in order to monetize its IP. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide.

About The Sera Labs, Inc.
The Sera Labs, Inc. ("Sera Labs"), a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™ SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories beauty, health & wellness, Sera Labs products are sold in major national drug, grocery chains, convenience stores, and mass retailers. Sera Labs also sell products under private label to major retailers, multi-level marketers, and direct-to-consumer (DTC) via online website orders, including opt-in subscriptions. For more information visit: www.seralabshealth.com and follow Sera Labs on Facebook and Instagram at @seratopical, as well as on Twitter at @sera_ labs.

About New to The Street
New to The Street is an FMW Media production that operates one of the longest-running U.S. and International sponsored and syndicated Nielsen Rated programming television brands, "New to The Street," and its blockchain show, "Exploring The Block." Since 2009, these brands have run biographical interview segment shows across major U.S. television networks. The paid-for-television programming platforms can potentially reach over 540 million homes in the U.S. and international markets. FMW's New to The Street / Newsmax televised broadcasting platform airs its syndication on Saturdays at 3:30 - 4:00 PM ET. FMW is also one of the nation's largest buyers of linear television and long and short-form paid programming -https://www.newsmaxtv.com/Shows/New-to-the Street & https://www.newtothestreet.com/.

Forward-Looking Statements Disclaimer
This press release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at which such performance or results are achieved. This press release should be considered in all filings of the companies contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

CONTACT:
FMW Media Contacts:
Bryan Johnson
T: (631) 766-7462
E: Bryan@NewToTheStreet.com

"New to The Street" Business Development Office
T: (516) 696-5900
E: Support@NewToTheStreet.com

Avenir Wellness Solutions Contacts:
Investor Relations
Hanover International Inc.
T: (760) 564-7400
E: investor@avenirwellness.com

Media
Rachel Moskowitz
Autumn Communications
T: (202) 276-7881
E: rmoskowitz@autumncommunications.com

SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)



View source version on accesswire.com:
https://www.accesswire.com/735866/Avenir-Wellness-Solutions-to-Launch-Wall-Street-focused-Informational-Series-with-Producer-New-to-The-Street

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière